SCHEMBL6168916

SCHEMBL6168916

C[SiH](C)OC(c1ccnc(C(=O)CBr)c1)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170313 0.84 ALDH1A1 (0.36)
SCHEMBL1166692 0.76 AR (0.30)
SCHEMBL6171579 0.75 CBLB (0.36)
SCHEMBL331280 0.73 NOS3 (0.39)
SCHEMBL7499934 0.72 CTSA (0.31)
SCHEMBL6171364 0.72 APLNR (0.31)
SCHEMBL1940995 0.71 GSK3B (0.40)
SCHEMBL1940488 0.70 AAK1 (0.35)
SCHEMBL5222824 0.69 MYC (0.31)
SCHEMBL6169010 0.69 PTGS1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed